Abstract:Background: Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for high- and intermediate-risk patients with severe symptomatic aortic valve stenosis. A majority of patients exhibit improvements in left ventricular ejection fraction (LVEF) after TAVR in response to TAVR-associated afterload reduction. However, a specific role for circulating microRNAs (miRNAs) in the improvement of cardiac function for patients after TAVR has not yet been investigated. Here, we profiled the differential expression of miRNAs in circulating extracellular vesicles (EVs) in patients after TAVR and, in particular, the novel role of circulating miR-122-5p in cardiomyocytes. Methods: Circulating EV-associated miRNAs were investigated by use of an unbiased Taqman-based human miRNA array. Several EV miRNAs (miR-122-5p, miR-26a, miR-192, miR-483-5p, miR-720, miR-885-5p, and miR-1274) were significantly deregulated in patients with aortic valve stenosis at day 7 after TAVR compared with the preprocedural levels in patients without LVEF improvement. The higher levels of miR-122-5p were negatively correlated with LVEF improvement at both day 7 (r=-0.264 and P=0.015) and 6 months (r=-0.328 and P=0.0018) after TAVR. Results: Using of patient-derived samples and a murine aortic valve stenosis model, we observed that the expression of miR-122-5p correlates negatively with cardiac function, which is associated with LVEF. Mice with graded wire injury-induced aortic valve stenosis demonstrated a higher level of miR-122-5p, which was related to cardiomyocyte dysfunction. Murine ex vivo experiments revealed that miR-122-5p is highly enriched in endothelial cells compared with cardiomyocytes. Coculture experiments, copy-number analysis, and fluorescence microscopy with Cy3-labeled miR-122-5p demonstrated that miR-122-5p can be shuttled through large EVs from endothelial cells into cardiomyocytes. Gain- and loss-of-function experiments suggested that EV-mediated shuttling of miR-122-5p increases the level of miR-122-5p in recipient cardiomyocytes. Mechanistically, mass spectrometry, miRNA pulldown, electrophoretic mobility shift assay, and RNA immunoprecipitation experiments confirmed that miR-122-5p interacts with the RNA-binding protein hnRNPU (heterogeneous nuclear ribonucleoprotein U) in a sequence-specific manner to encapsulate miR-122-5p into large EVs. On shuttling, miR-122-5p reduces the expression of the antiapoptotic gene BCL2 by binding to its 3' untranslated region to inhibit its translation, thereby decreasing the viability of target cardiomyocytes. Conclusions: Increased levels of circulating proapoptotic EV-incorporated miR-122-5p are associated with reduced LVEF after TAVR. EV shuttling of miR-122-5p regulates the viability and apoptosis of cardiomyocytes in a BCL2-dependent manner.

MicroRNA Profiling of Plasma Extracellular Vesicles in Bicuspid Aortopathy

Plasma Exosomal Mir-423-5p is Involved in the Occurrence and Development of Bicuspid Aortopathy Via TGF-β/SMAD2 Pathway

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Plasma proteomic profiling reveals biomarkers associated with aortic dilation in patients with bicuspid aortic valve

The Etiological Heterogeneity of Bicuspid Aortopathy Between Ascending and Root Morphotype

MicroRNAs Involve in Bicuspid Aortic Aneurysm: Pathogenesis and Biomarkers

Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease

Pro-angiogenic Cytokine Features for Left Ventricular Remodeling in Patients with Bicuspid Aortic Valve

Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease

Signature Of Circulating Micrornas As Potential Biomarkers In Vulnerable Coronary Artery Disease

Connecting the dots: molecular pathways in bicuspid aortopathy explored

Two MicroRNAs, Mir-34A and Mir-125A, Are Implicated in Bicuspid Aortopathy by Modulating Metalloproteinase 2

Targeted Next-Generation Sequencing Identified ADAMTS5 As Novel Genetic Substrate in Patients with Bicuspid Aortic Valve.

Diagnostic Plasma Small Extracellular Vesicles Mirna Signatures for Pancreatic Cancer Using Machine Learning Methods

Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles

Circulating Matrix Metalloproteinase Patterns in Association with Aortic Dilatation in Bicuspid Aortic Valve Patients with Isolated Severe Aortic Stenosis

Prognostic Role of Aortic Distensibility in Patients with Bicuspid Aortic Valve: a CMR Study

Aorta-on-a-chip reveals impaired mitochondrial dynamics as a therapeutic target for aortic aneurysm in bicuspid aortic valve disease

Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing

Microrna-155 As A Potential Plasma Non-Invasive Biomarker For The Diagnosis And Prognosis Of Abdominal Aortic Aneurysm

Metabolic plasma signatures in thoracic aortic aneurysm associated to tricuspid and bicuspid aortic valves